An anonymous donor has made a $20 million commitment to the cellular immunotherapy program at the UNC Lineberger Comprehensive Cancer Center, the University announced today. The gift will support all aspects of the program, with emphasis on clinical trials to test treatments that show the most immediate promise. It will also help provide for expansion of Lineberger’s advanced cellular therapeutics facility and recruitment and retention of top research faculty.
Cellular immunotherapy involves removing a patient’s immune cells, modifying and increasing their number in a special lab, and then reintroducing them into the patient to kill cancer cells. Most academic medical centers do not have such a facility, but UNC Lineberger is one of several institutions with this capability.
“At UNC Lineberger, therapies designed and manufactured in Chapel Hill are moving from discovery to clinical trials, creating new possibilities for patients with few other options,” Chancellor Lee Roberts said in a statement. “This extraordinary commitment will strengthen that work and our ability to serve people across North Carolina while advancing care nationwide.”
UNC Lineberger’s facility was constructed and federally approved for use in 2016, and researchers first began using it for clinical trials that same year. Since then, Lineberger oncologists have created cellular immunotherapies to conduct clinical trials and help extend the lives of patients with various types of cancer, including lymphoma, neuroblastoma, glioblastoma, lung cancer, head and neck cancers, pancreatic cancer, triple-negative breast cancer and ovarian cancer. And they are planning studies of acute myelogenous leukemia, according to the University’s statement.
“This incredible commitment to our Cellular Immunotherapy Program is an investment in innovative research, clinical excellence and, most importantly, better outcomes for patients and families from across North Carolina and around the world who have been impacted by cancer,” said Robert Ferris ’90, executive director of UNC Lineberger. “Our internationally renowned experts in the field of immunotherapy have made UNC Lineberger a destination for world-leading science and a commitment to compassionate care, and I am grateful for a gift of this magnitude that will help us continue to lead the way.”